Vktx nasdaq.

The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on December 4, 2023.The analyst firm set a price target for $32.00 expecting VKTX to rise to within ...Dec 1, 2023 · Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock. SAN DIEGO , March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic a... 8 months ago - PRNewsWire. Fintel reports that on May 16, 2023, Oppenheimer maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Outperform recommendation.. Analyst Price Forecast Suggests 35.91% Upside. As of ...That's the story for Viking Therapeutics ' ( VKTX 6.46%) share price so far this year. The stock jumped nearly 26% year to date by early March. It subsequently gave up all of those gains and then ...VKTX data by YCharts. Which low-priced healthcare stocks might be the next big movers? Wall Street analysts think Agenus ( AGEN 1.60% ) and Aclaris Therapeutics ( ACRS 3.01% ) could deliver market ...

VKTX Viking Therapeutics Inc Viking Therapeutics to Present at SVB Securities Global Biopharma ConferenceViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2023 Earnings Conference Call April 26, 2023 4:30 PM ETCompany Participants. Stephanie Diaz - Manager of Investor Relations. Brian Lian - Viking’s ...

Viking Therapeutics, Inc. Common Stock (VKTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Of the funds tracked by Insider Monkey, Peter S. Park's Park West Asset Management has the largest position in Viking Therapeutics, Inc. (NASDAQ:VKTX), worth close to $12 million, accounting for 0 ...Investing.com - Viking Therapeutics Inc (NASDAQ: VKTX) reported third quarter EPS of $-0.230, $0.01 worse than the analyst estimate of $-0.220. Revenue for the quarter came in at... After-Hours Stock Movers: Viking Therapeutics, Inc. (NASDAQ:VKTX) 6% HIGHER; announced that new results from the company's Phase 1 single ascending dose (SAD) …Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Viking Therapeutics, Inc. (VKTX) NasdaqCM - NasdaqCM Real... VKTX News. This page features the latest news about the Viking Therapeutics Inc stock. ... Which NASDAQ companies generate more than $100 billion a year?

Here's why they chose Bluebird Bio (NASDAQ: BLUE), Travere Therapeutics (NASDAQ: TVTX), and Viking Therapeutics (NASDAQ: VKTX). The upside is huge, but beware of the risks .

As of February 3, 2023, the average one-year price target for Viking Therapeutics is $18.70. The forecasts range from a low of $11.11 to a high of $31.50. The average price target represents an ...

In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), with a price target of $35.00.The company’s shares opened ...On September 8, 2023, analysis has identified a bullish chart pattern known as the "Bottom Triangle" on Viking Therapeutics Inc (VKTX:NASDAQ). This bullish pattern suggests the potential for a ...Jul 10, 2023 · Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Quantitative Momentum Investor model based on the ... VKTX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. VIKING THERAPEUTICS, INC. (VKTX) Compare. VIKING THERAPEUTICS, INC. 15.39 ...The company is Viking Therapeutics ( NASDAQ: VKTX) which was basically offering a lower valuation as compared to other stocks in the NASH-related biotech field. Picking two competitors for example ...VKTX News. This page features the latest news about the Viking Therapeutics Inc stock. ... Which NASDAQ companies generate more than $100 billion a year?Find real-time VKTX - Viking Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Viking Therapeutics Inc (NASDAQ:VKTX) trade information. Sporting 10.61% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, 12/01/23 when the VKTX stock price touched $14.39 or saw a rise of 3.62%. Year-to-date, Viking Therapeutics Inc shares have moved 53.09%, while the 5 …SAN DIEGO, Feb. 8, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the fourth quarter and year ended December 31, 2022, and provided an update on its ...VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: …Stock analysis for Viking Therapeutics Inc (VKTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.P/E & PEG Ratios. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Viking Therapeutics ( VKTX – Research Report) yesterday and set a price target of $40.00. The company’s shares closed yesterday at $24. ...Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine analysts that are presently covering the …

Nov 21, 2023 · VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 55% based on the firm’s underlying fundamentals and the stock ... The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.May 11, 2023 · As of May 11, 2023, the average one-year price target for Viking Therapeutics is 29.89. The forecasts range from a low of 23.23 to a high of $36.75. The average price target represents an increase ... Dec 1, 2023 · Viking Therapeutics last announced its quarterly earnings data on October 25th, 2023. The biotechnology company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.01. Viking Therapeutics has generated ($0.93) earnings per share over the last year ( ($0.93) diluted earnings per share). VKTX VKTX AFTER HOURS QUOTE VKTX LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ...Find the latest Insider Activity data for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.The announcement has buoyed biotechs with oral weight loss candidates in development, such as Viking Therapeutics (NASDAQ:VKTX) and Structure Therapeutics (NASDAQ:GPCR).

NAV / 1-Day Return 392.46 / 0.42 %. Total Assets 2.7 Bil. Adj. Expense Ratio 0.080%. Expense Ratio 0.080%. Distribution Fee Level Low. Share Class Type Institutional. Category Large Blend ...

Dec 4, 2023 · Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have covered the stock in the […]

As of February 3, 2023, the average one-year price target for Viking Therapeutics is $18.70. The forecasts range from a low of $11.11 to a high of $31.50. The average price target represents an ... Novavax Stock Is Going to Recover, Says 5-Star Analyst. After a disastrous 2022 impacted by underwhelming sales of its Covid-19 vaccine NVX-CoV2373, which saw the shares lose a brutal 93% of their ...Viking Therapeutics Inc stock price live 13.010, this page displays NASDAQ VKTX stock exchange data. View the VKTX premarket stock price ahead of the market session or assess the after hours quote.Fintel reports that on April 27, 2023, HC Wainwright & Co. maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation. Analyst Price Forecast Suggests 41.39% Upside. As of ...Oct 25, 2023 · Viking Therapeutics Inc ( NASDAQ:VKTX) reported a strong quarter-end cash position of $376M. The company's net loss for Q3 2023 was $22.5 million, or $0.23 per share, compared to a net loss of $15 ... Find the latest Viking Therapeutics, Inc. (VKTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ... Nasdaq 14,305.03 +78.83 ...Investing.com - Viking Therapeutics Inc (NASDAQ: VKTX) reported third quarter EPS of $-0.230, $0.01 worse than the analyst estimate of $-0.220. Revenue for the quarter came in at... After-Hours Stock Movers: Viking Therapeutics, Inc. (NASDAQ:VKTX) 6% HIGHER; announced that new results from the company's Phase 1 single ascending dose (SAD) …Mar. 28, 2023, 08:37 AM. Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of ...

Turning to the calls side of the option chain, the call contract at the $17.00 strike price has a current bid of $3.50. If an investor was to purchase shares of VKTX stock at the current price ...MSFT. Microsoft Corporation Common Stock. $352.60 -0.20 -0.06%. Viking Therapeutics, Inc. Common Stock (VKTX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ... Shares of Viking Therapeutics (NASDAQ: VKTX) are trading down over 15% late into Tuesday's session, in a move linked to the disappointing clinical data posted by VKTX's competitor Altimmune, Inc ...VKTX: Viking Therapeutics broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. ... NASDAQ data is at least 15 minutes delayed.Instagram:https://instagram. fractional real estate investingbest high leverage forex brokerskmb stock dividendiphone q4 Apr 24, 2023 · Average portfolio weight of all funds dedicated to VKTX is 0.12%, an increase of 480.40%. Total shares owned by institutions increased in the last three months by 27.67% to 35,011K shares. susa etfbest growing stocks to buy March 29, 2023 at 11:12 AM · 4 min read. Shares of Viking Therapeutics VKTX have surged almost 70% on Mar 28, after it announced positive clinical data of VK2735, a novel dual agonist of the ... bank stock etf Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b studyViking Therapeutics Inc (NASDAQ:VKTX)’s Major holders. Insiders own 5.89% of the company shares, while shares held by institutions stand at 68.75% with a share float percentage of 73.05%. Investors are also buoyed by the number of investors in a company, with Viking Therapeutics Inc having a total of 246 institutions that hold shares in the ...